AERI - Aerie Pharmaceuticals Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript
Aerie Pharmaceuticals, Inc. (AERI) Q4 2021 Earnings Conference Call February 24, 2022, 17:00 ET Company Participants Hans Vitzthum - LifeSci Advisors Raj Kannan - CEO & Director Michelle Senchyna - Head, Clinical Development and Medical Affairs Jeffrey Calabrese - Director, Accounting Conference Call Participants François Brisebois - Oppenheimer Louise Chen - Cantor Fitzgerald & Co. Stacy Ku - Cowen and Company Annabel Samimy - Stifel, Nicolaus & Company Serge Belanger - Needham & Company Carly Kenselaar - Citigroup Jason Gerberry - Bank of America Merrill Lynch Gregory Fraser - Truist Securities Presentation Operator Good afternoon. Thank you for standing by, and welcome to the Aerie Pharmaceuticals Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Instructions]. Today's conference will be recorded. It is now my pleasure to turn the floor over to Hans Vitzthum of LifeSci Partners, Aerie's Investor Relations firm. Please go ahead. Hans Vitzthum Thank you, operator.
For further details see:
Aerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript